ERBB2 and breast cancer: Basal-like and HER2+ tumors exhibited a higher frequency of ALDH1+ cells compared to luminal tumors, and a higher percentage of CD44+/CD24− cells is mainly attributed to TNBC and to BRCA1-mutated BC [51,91].